Protein can hold off AML relapse, scientists say

04/19/2013 | Japan Daily Press, The

Researchers at the Riken Center for Integrative Medical Sciences in Japan found that a protein called HCK may help prevent the recurrence of acute myeloid leukemia. The researchers tested thousands of molecules and isolated one molecule activated against the cells that cause the relapse, according to findings published in Science Translational Medicine. Researchers said tests on a mouse model showed the molecule can reduce AML cells in the blood and bone marrow, but more research is needed before it can be administered to humans.

View Full Article in:

Japan Daily Press, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA